Search reports.
Alopecia Areata Market Size, Analysis, Share & Forecast 2031
Get free sample report Request for Customiztion Buy Now

Alopecia Areata Market Size, Analysis, Share & Forecast 2031

Segments - Alopecia Areata Market by Types (Alopecia Areata (Patchy), Persistent Patchy Alopecia Areata, Alopecia Areata Totalis, Diffuse Alopecia Areata, Alopecia Areata Universalis, Ophiasis Alopecia Areata, and Others), Diagnosis (Skin Biopsy, Trichoscopy, Blood Test, and Others), Treatments (Corticosteroid Drugs, Steroids, Anti-Inflammatory Drugs, Vasodilator, Immunosuppressive Drugs, UV Light Therapy, and Others), Routes of Administration (Topical, Oral, Parenteral, and Others), Distributions Channels (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, and Others), End-users (Specialty Clinics, Hospitals, Homecare, and Others), and Regions (Asia Pacific, North America, Latin America, Europe and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4301 | 4.5 Rating | 66 Reviews | 166 Pages | Format : PDF Excel PPT

Report Description


Alopecia Areata Market Outlook 2031:

The global alopecia areata market size was valued at USD 2.96 Billion in 2022 and is projected to reach USD 5.04 Billion by 2031, expanding at a CAGR of 10% during the forecast period 2023 - 2031. The growth of the market is attributed to the rising prevalence of hair loss.

Alopecia areata is a type of alopecia, which refers to an autoimmune disorder, which causes hair fall or hair loss in oval or round shape and in patches. Alopecia areata is unpredictable, where hair can regrow after some bald patches. Conversely, sometimes hair do not grow back and bald patches can expand. Rash, redness, and scarring can appear on the bare spots. Itching, burning, or tingling can be felt in these patches as well.

Alopecia Areata Market Outlook

Alopecia areata primarily affects hair; however, in some cases, it can affect nails as well. Ridges and pits can occur on nails for some people affected by severe hair loss. Anyone can develop alopecia areata; however, individuals related to a person suffering from the disease or other autoimmune disorders such as lupus, diabetes, and thyroid have high chances of contracting alopecia areata.

  • Growing investments in healthcare infrastructure boosts the market.
  • Increasing prevalence of alopecia areata across the globe is expected to drive the market during the forecast period.
  • Rising awareness regarding alopecia areata is estimated to fuel the market in the coming years.
  • Rising cases of autoimmune diseases and fast changing lifestyle spurs the market.
  • High cost of alopecia areata treatment is expected to hamper the growth of the market during the forecast period.
  • Lack of awareness regarding the diseases in developing countries hinders the growth of the market.
  • Increasing number of research and development activities regarding alopecia areata offer growth opportunities to the key market players.

Scope of the Alopecia Areata Report

The report on the global alopecia areata market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Alopecia Areata Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2021

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Types (Alopecia Areata (Patchy), Persistent Patchy Alopecia Areata, Alopecia Areata Totalis, Diffuse Alopecia Areata, Alopecia Areata Universalis, Ophiasis Alopecia Areata, and Others), Diagnosis (Skin Biopsy, Trichoscopy, Blood Test, and Others), Treatments (Corticosteroid Drugs, Steroids, Anti-Inflammatory Drugs, Vasodilator, Immunosuppressive Drugs, UV Light Therapy, and Others), Routes of Administration (Topical, Oral, Parenteral, and Others), Distributions Channels (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, and Others), and End-users (Specialty Clinics, Hospitals, Homecare, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Pfizer, Inc.; Bayer AG; Cipla, Inc.; Teva Pharmaceuticals Industries Ltd.; Aclaris Therapeutics, Inc.; Sanofi; Mylan N.V.; Novartis AG; GSK Group of Companies; AbbVie, Inc.; Lupin; Merck KGaA; Sun Pharmaceuticals Industries, Ltd.; AstraZeneca; Eli Lilly and Company; Perrigo Company plc; and Others

Alopecia Areata Market Segment Insights

Alopecia areata (patchy) segment drives the market

Based on Types, the market is divided into alopecia areata (patchy), persistent patchy alopecia areata, alopecia areata totalis, diffuse alopecia areata, alopecia areata universalis, ophiasis alopecia areata, and others.

The alopecia areata (patchy) segment is expected to boost the market during the forecast period, due to increasing prevalence of individuals suffering from autoimmune disorders. Rapidly changing lifestyle and increasing stress among individuals across the globe are key factors, which aid in the expansion of the market.

Alopecia Areata Market Types

Blood test segment boosts the market

In terms of diagnosis, the market is segregated into skin biopsy, trichoscopy, blood test, and others. The blood test segment is projected to drive the market during the forecast period, as doctors can check for medical conditions such as thyroid, immune system problems, hormone, and others that can cause hair loss.

Corticosteroid drugs segment holds a key market share

On the basis of treatments, the market is segmented into corticosteroid drugs, steroids, anti-Inflammatory drugs, vasodilator, immunosuppressive drugs, UV light therapy, and others.

The corticosteroid drugs segment is estimates to fuel the market during the forecast period, due to their lipid-regulating and anti-inflammatory properties. Increasing usage of corticosteroid drugs in clinical trials aids in the expansion of the segment.

Topical segment registers a high CAGR

In terms of routes of administrations, the market is divided into topical, oral, parenteral, and others. The topical segment is estimated to hold a key market share during the forecast period, owing to increasing demand for topical alopecia areata treatments.

The topical treatment solutions such as medicated hair serum, medicated shampoos, gel, and topical ointment are easily available, easy to use, and non-invasive. Increasing research and development activities in topical treatment solutions aid in the expansion of the segment.

Hospital pharmacy segment spurs the market

Based on distribution channels, the market is segregated into hospital pharmacy, online pharmacy, retail pharmacy, and others. The hospital pharmacy segment is estimated to fuel the market during the forecast period, due to easy availability of alopecia areata treatment prescription drugs in hospital pharmacies.

The online pharmacy segment is anticipated to expand in the coming years, owing to growing penetration of internet, increasing usage of smart devices, rising number of online pharmacies, and increasing benefits of purchasing from online pharmacies such as wide range of products, product comparison, door-step delivery, easy payment methods, and others.

Specialty clinic expands rapidly

On the basis of end-users, the market is distributed into specialty clinics, hospitals, homecare, and others. The specialty clinics segment is expected to drive the market during the forecast period, due to growing number of trichologists and dermatologist across the globe.

Increasing awareness regarding alopecia areata and benefits of hair treatment is drawing individuals across the globe to specialty clinics. These factors aid in the expansion of the segment.

Alopecia Areata Market End User

North America dominates the market

In terms of regions, the market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is estimated to hold a significant market share during the forecast period, due to increasing research and development activities regarding alopecia areata in the region.

Increasing cases of hair loss, growing expenditure in healthcare sector, rising early phase diagnosis of the disease, and favorable government policies for hair care companies drive the market in the region. The market in Asia pacific is anticipated to register a high CAGR during the forecast period, owing to increasing cases of alopecia areata among young population, rapidly changing lifestyle, and rising awareness regarding alopecia areata in the region.

Alopecia Areata Market Region

Segments

The global alopecia areata market has been segmented on the basis of

Types

  • Alopecia Areata (Patchy)
  • Persistent Patchy Alopecia Areata
  • Alopecia Areata Totalis
  • Diffuse Alopecia Areata Areata
  • Alopecia Areata Universalis
  • Ophiasis Alopecia Areata
  • Others

Diagnosis

  • Skin Biopsy
  • Trichoscopy
  • Blood Test
  • Others

Treatments

  • Corticosteroid Drugs
  • Steroids
  • Anti-Inflammatory Drugs
  • Vasodilator
  • Immunosuppressive Drugs
  • UV Light Therapy
  • Others

Routes of Administration

  • Topical
  • Oral
  • Parenteral
  • Others

Distributions Channels

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

End-users

  • Specialty Clinics
  • Hospitals
  • Homecare
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Pfizer, Inc.
  • Bayer AG
  • Cipla, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Aclaris Therapeutics, Inc.
  • Sanofi
  • Mylan N.V.
  • Novartis AG
  • GSK Group of Companies
  • AbbVie, Inc.
  • Lupin
  • Merck KGaA
  • Sun Pharmaceuticals Industries, Ltd.
  • AstraZeneca
  • Eli Lilly and Company
  • Perrigo Company plc
  • Others

Competitive Landscape

The global alopecia areata market is competitive with the presence of key players such as Pfizer, Inc.; Bayer AG; Cipla, Inc.; Teva Pharmaceuticals Industries Ltd.; Aclaris Therapeutics, Inc.; Sanofi; Mylan N.V.; Novartis AG; GSK Group of Companies; AbbVie, Inc.; Lupin; Merck KGaA; Sun Pharmaceuticals Industries, Ltd.; AstraZeneca; Eli Lilly and Company; Perrigo Company plc; and others, who use strategies such as acquisitions, mergers, collaborations, product launches, and partnerships to strengthen their hold on the market.

For example, in March 2020, Eli Lily and Company collaborated with Incyte Corporation to formulate a treatment for alopecia areata, which received a breakthrough therapy designation from the US Food and Drug Administration.

In July 2019, Aclaris Therapeutics, Inc. announced a positive result for ATI-501, which is an oral drug for treating alopecia areata.

Alopecia Areata Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Alopecia Areata Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Alopecia Areata Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Alopecia Areata Market - Supply Chain
  4.5. Global Alopecia Areata Market Forecast
     4.5.1. Alopecia Areata Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Alopecia Areata Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Alopecia Areata Market Absolute $ Opportunity
5. Global Alopecia Areata Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Alopecia Areata Market Size and Volume Forecast by Types
     5.3.1. Alopecia Areata (Patchy)
     5.3.2. Persistent Patchy Alopecia Areata
     5.3.3. Alopecia Areata Totalis
     5.3.4. Diffuse Alopecia Areata Areata
     5.3.5. Alopecia Areata Universalis
     5.3.6. Ophiasis Alopecia Areata
     5.3.7. Others
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Alopecia Areata Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Alopecia Areata Market Size and Volume Forecast by End Users
     6.3.1. Specialty Clinics
     6.3.2. Hospitals
     6.3.3. Homecare
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Alopecia Areata Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Alopecia Areata Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Alopecia Areata Demand Share Forecast, 2019-2026
8. North America Alopecia Areata Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Alopecia Areata Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Alopecia Areata Market Size and Volume Forecast by Types
     8.4.1. Alopecia Areata (Patchy)
     8.4.2. Persistent Patchy Alopecia Areata
     8.4.3. Alopecia Areata Totalis
     8.4.4. Diffuse Alopecia Areata Areata
     8.4.5. Alopecia Areata Universalis
     8.4.6. Ophiasis Alopecia Areata
     8.4.7. Others
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Alopecia Areata Market Size and Volume Forecast by End Users
     8.7.1. Specialty Clinics
     8.7.2. Hospitals
     8.7.3. Homecare
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Alopecia Areata Demand Share Forecast, 2019-2026
9. Latin America Alopecia Areata Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Alopecia Areata Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Alopecia Areata Market Size and Volume Forecast by Types
     9.4.1. Alopecia Areata (Patchy)
     9.4.2. Persistent Patchy Alopecia Areata
     9.4.3. Alopecia Areata Totalis
     9.4.4. Diffuse Alopecia Areata Areata
     9.4.5. Alopecia Areata Universalis
     9.4.6. Ophiasis Alopecia Areata
     9.4.7. Others
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Alopecia Areata Market Size and Volume Forecast by End Users
     9.7.1. Specialty Clinics
     9.7.2. Hospitals
     9.7.3. Homecare
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Alopecia Areata Demand Share Forecast, 2019-2026
10. Europe Alopecia Areata Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Alopecia Areata Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Alopecia Areata Market Size and Volume Forecast by Types
     10.4.1. Alopecia Areata (Patchy)
     10.4.2. Persistent Patchy Alopecia Areata
     10.4.3. Alopecia Areata Totalis
     10.4.4. Diffuse Alopecia Areata Areata
     10.4.5. Alopecia Areata Universalis
     10.4.6. Ophiasis Alopecia Areata
     10.4.7. Others
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Alopecia Areata Market Size and Volume Forecast by End Users
     10.7.1. Specialty Clinics
     10.7.2. Hospitals
     10.7.3. Homecare
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Alopecia Areata Demand Share Forecast, 2019-2026
11. Asia Pacific Alopecia Areata Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Alopecia Areata Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Alopecia Areata Market Size and Volume Forecast by Types
     11.4.1. Alopecia Areata (Patchy)
     11.4.2. Persistent Patchy Alopecia Areata
     11.4.3. Alopecia Areata Totalis
     11.4.4. Diffuse Alopecia Areata Areata
     11.4.5. Alopecia Areata Universalis
     11.4.6. Ophiasis Alopecia Areata
     11.4.7. Others
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Alopecia Areata Market Size and Volume Forecast by End Users
     11.7.1. Specialty Clinics
     11.7.2. Hospitals
     11.7.3. Homecare
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Alopecia Areata Demand Share Forecast, 2019-2026
12. Middle East & Africa Alopecia Areata Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Alopecia Areata Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Alopecia Areata Market Size and Volume Forecast by Types
     12.4.1. Alopecia Areata (Patchy)
     12.4.2. Persistent Patchy Alopecia Areata
     12.4.3. Alopecia Areata Totalis
     12.4.4. Diffuse Alopecia Areata Areata
     12.4.5. Alopecia Areata Universalis
     12.4.6. Ophiasis Alopecia Areata
     12.4.7. Others
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Alopecia Areata Market Size and Volume Forecast by End Users
     12.7.1. Specialty Clinics
     12.7.2. Hospitals
     12.7.3. Homecare
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Alopecia Areata Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Alopecia Areata Market: Market Share Analysis
  13.2. Alopecia Areata Distributors and Customers
  13.3. Alopecia Areata Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Pfizer, Inc.
     13.4.2. Bayer AG
     13.4.3. Cipla, Inc.
     13.4.4. Teva Pharmaceuticals Industries Ltd.
     13.4.5. Aclaris Therapeutics, Inc.
     13.4.6. Sanofi
     13.4.7. Mylan N.V.
     13.4.8. Novartis AG
     13.4.9. GSK Group of Companies
     13.4.10. AbbVie, Inc.
     13.4.11. Lupin

Methodology

Our Clients

General Mills
Microsoft
Siemens Healthcare
Nestle SA
FedEx Logistics
General Electric
Honda Motor Co. Ltd.
The John Holland Group